Statistics for A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease
Total visits
views | |
---|---|
A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease | 234 |
Total visits per month
views | |
---|---|
April 2024 | 0 |
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
File Visits
views | |
---|---|
Weir_2017_US.pdf | 481 |
Top country views
views | |
---|---|
United States | 177 |
Germany | 7 |
Ukraine | 7 |
China | 4 |
United Kingdom | 4 |
Russia | 3 |
Thailand | 3 |
Canada | 2 |
India | 2 |
Switzerland | 1 |
Czechia | 1 |
Italy | 1 |
South Korea | 1 |
Malaysia | 1 |
Singapore | 1 |
Top city views
views | |
---|---|
Wilmington | 52 |
Fairfield | 23 |
Houston | 14 |
Ann Arbor | 11 |
Jacksonville | 7 |
Kiev | 7 |
Cambridge | 6 |
Kiez | 6 |
Beijing | 3 |
San Francisco | 3 |
Washington | 3 |
Arkadelphia | 2 |
Baltimore | 2 |
Bangkok | 2 |
Mumbai | 2 |
Saint Petersburg | 2 |
Seattle | 2 |
Toronto | 2 |
Basel | 1 |
Bloomington | 1 |
Brooklyn | 1 |
Columbia | 1 |
Fort Washington | 1 |
Gunzenhausen | 1 |
Irvine | 1 |
Lake Mary | 1 |
Monmouth Junction | 1 |
Moscow | 1 |
Overland Park | 1 |
Philadelphia | 1 |
Rome | 1 |
Scottsdale | 1 |
Seremban | 1 |
Shenzhen | 1 |
Uherske Hradiste | 1 |
White Plains | 1 |
Woburn | 1 |
Yongin-si | 1 |